Skip to main content
Article thumbnail
Location of Repository

Large family with both parents affected by distinct BRCA1 mutations: implications for genetic testing

By Anna P Sokolenko, Dmitry A Voskresenskiy, Aglaya G Iyevleva, Elena M Bit-Sava, Nadezhda I Gutkina, Maxim S Anisimenko, Nathalia Yu Sherina, Nathalia V Mitiushkina, Yulia M Ulibina, Olga S Yatsuk, Olga A Zaitseva, Evgeny N Suspitsin, Alexandr V Togo, Valery A Pospelov, Sergey P Kovalenko, Vladimir F Semiglazov and Evgeny N Imyanitov


Although the probability of both parents being affected by BRCA1 mutations is not negligible, such families have not been systematically described in the literature. Here we present a large breast-ovarian cancer family, where 3 sisters and 1 half-sister inherited maternal BRCA1 5382insC mutation while the remaining 2 sisters carried paternal BRCA1 1629delC allele. No BRCA1 homozygous mutations has been detected, that is consistent with the data on lethality of BRCA1 knockout mice. This report exemplifies that the identification of a single cancer-predisposing mutation within the index patient may not be sufficient in some circumstances. Ideally, all family members affected by breast or ovarian tumor disease have to be subjected to the DNA testing, and failure to detect the mutation in any of them calls for the search of the second cancer-associated allele

Topics: Case Report
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (1996). BH: Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nat Genet
  2. (2001). BL: Breast cancer genetics: what we know and what we need. Nat Med
  3. (2005). Breast cancer predisposing alleles in Poland. Breast Cancer Res Treat
  4. (2001). CB: The lifetime risks of breast cancer
  5. (1995). DM: A human BRCA1 gene knockout. Nature
  6. (2004). Foulkes WD: BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer
  7. (2003). Hereditary ovarian cancer in Poland.
  8. (2007). Imyanitov EN: Founder mutations in early-onset, familial and bilateral breast cancer patients from Russia. Fam Cancer
  9. (2007). Offit K: Clinical practice. Management of an inherited predisposition to breast cancer.
  10. (2005). Oosterwijk JC: Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations.
  11. (2001). Pharoah PD: Apparent human BRCA1 knockout caused by mispriming during polymerase chain reaction: implications for genetic testing. Genes Chromosomes Cancer
  12. (2001). SK: Human BRCA1 gene rescues the embryonic lethality of Brca1 mutant mice. Genesis
  13. (1996). Thomas G: Segregation of two BRCA1 mutations in a single family.
  14. (1996). TW: The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell
  15. (2004). West DW: Prevalence of BRCA1 mutation carriers among U.S. non-Hispanic Whites. Cancer Epidemiol Biomarkers Prev

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.